Literature DB >> 33188779

Remodeling of the m6A landscape in the heart reveals few conserved post-transcriptional events underlying cardiomyocyte hypertrophy.

Scott A Hinger1, Jiangbo Wei2, Lisa E Dorn1, Bryan A Whitson3, Paul M L Janssen1, Chuan He2, Federica Accornero4.   

Abstract

Regulation of gene expression plays a fundamental role in cardiac stress-responses. Modification of coding transcripts by adenosine methylation (m6A) has recently emerged as a critical post-transcriptional mechanism underlying heart disease. Thousands of mammalian mRNAs are known to be m6A-modified, suggesting that remodeling of the m6A landscape may play an important role in cardiac pathophysiology. Here we found an increase in m6A content in human heart failure samples. We then adopted genome-wide analysis to define all m6A-regulated sites in human failing compared to non-failing hearts and identified targeted transcripts involved in histone modification as enriched in heart failure. Further, we compared all m6A sites regulated in human hearts with the ones occurring in isolated rat hypertrophic cardiomyocytes to define cardiomyocyte-specific m6A events conserved across species. Our results identified 38 shared transcripts targeted by m6A during stress conditions, and 11 events that are unique to unstressed cardiomyocytes. Of these, further evaluation of select mRNA and protein abundances demonstrates the potential impact of m6A on post-transcriptional regulation of gene expression in the heart.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiomyocyte hypertrophy; Epigenetics; Gene expression; Heart failure; m(6)A

Mesh:

Substances:

Year:  2020        PMID: 33188779      PMCID: PMC7880874          DOI: 10.1016/j.yjmcc.2020.11.002

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  39 in total

1.  Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation.

Authors:  Eric C Lai
Journal:  Nat Genet       Date:  2002-03-18       Impact factor: 38.330

2.  The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo.

Authors:  Q Liang; L J De Windt; S A Witt; T R Kimball; B E Markham; J D Molkentin
Journal:  J Biol Chem       Date:  2001-05-16       Impact factor: 5.157

3.  Exome-based analysis for RNA epigenome sequencing data.

Authors:  Jia Meng; Xiaodong Cui; Manjeet K Rao; Yidong Chen; Yufei Huang
Journal:  Bioinformatics       Date:  2013-04-14       Impact factor: 6.937

4.  Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons.

Authors:  Kate D Meyer; Yogesh Saletore; Paul Zumbo; Olivier Elemento; Christopher E Mason; Samie R Jaffrey
Journal:  Cell       Date:  2012-05-17       Impact factor: 41.582

5.  Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy.

Authors:  Chun Li Zhang; Timothy A McKinsey; Shurong Chang; Christopher L Antos; Joseph A Hill; Eric N Olson
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

6.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

7.  Ensembl 2019.

Authors:  Fiona Cunningham; Premanand Achuthan; Wasiu Akanni; James Allen; M Ridwan Amode; Irina M Armean; Ruth Bennett; Jyothish Bhai; Konstantinos Billis; Sanjay Boddu; Carla Cummins; Claire Davidson; Kamalkumar Jayantilal Dodiya; Astrid Gall; Carlos García Girón; Laurent Gil; Tiago Grego; Leanne Haggerty; Erin Haskell; Thibaut Hourlier; Osagie G Izuogu; Sophie H Janacek; Thomas Juettemann; Mike Kay; Matthew R Laird; Ilias Lavidas; Zhicheng Liu; Jane E Loveland; José C Marugán; Thomas Maurel; Aoife C McMahon; Benjamin Moore; Joannella Morales; Jonathan M Mudge; Michael Nuhn; Denye Ogeh; Anne Parker; Andrew Parton; Mateus Patricio; Ahamed Imran Abdul Salam; Bianca M Schmitt; Helen Schuilenburg; Dan Sheppard; Helen Sparrow; Eloise Stapleton; Marek Szuba; Kieron Taylor; Glen Threadgold; Anja Thormann; Alessandro Vullo; Brandon Walts; Andrea Winterbottom; Amonida Zadissa; Marc Chakiachvili; Adam Frankish; Sarah E Hunt; Myrto Kostadima; Nick Langridge; Fergal J Martin; Matthieu Muffato; Emily Perry; Magali Ruffier; Daniel M Staines; Stephen J Trevanion; Bronwen L Aken; Andrew D Yates; Daniel R Zerbino; Paul Flicek
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

8.  WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs.

Authors:  Yuxing Liao; Jing Wang; Eric J Jaehnig; Zhiao Shi; Bing Zhang
Journal:  Nucleic Acids Res       Date:  2019-07-02       Impact factor: 16.971

9.  Monitoring Cell-Type-Specific Gene Expression Using Ribosome Profiling In Vivo During Cardiac Hemodynamic Stress.

Authors:  Shirin Doroudgar; Christoph Hofmann; Etienne Boileau; Brandon Malone; Eva Riechert; Agnieszka A Gorska; Tobias Jakobi; Clara Sandmann; Lonny Jürgensen; Vivien Kmietczyk; Ellen Malovrh; Jana Burghaus; Mandy Rettel; Frank Stein; Fereshteh Younesi; Ulrike A Friedrich; Victoria Mauz; Johannes Backs; Günter Kramer; Hugo A Katus; Christoph Dieterich; Mirko Völkers
Journal:  Circ Res       Date:  2019-07-09       Impact factor: 17.367

10.  BEX1 is an RNA-dependent mediator of cardiomyopathy.

Authors:  Federica Accornero; Tobias G Schips; Jennifer M Petrosino; Shan-Qing Gu; Onur Kanisicak; Jop H van Berlo; Jeffery D Molkentin
Journal:  Nat Commun       Date:  2017-11-30       Impact factor: 14.919

View more
  13 in total

1.  METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221/222 maturation in an m6A-dependent manner.

Authors:  Rui Zhang; Yangyang Qu; Zhenjun Ji; Chunshu Hao; Yamin Su; Yuyu Yao; Wenjie Zuo; Xi Chen; Mingming Yang; Genshan Ma
Journal:  Cell Mol Biol Lett       Date:  2022-07-14       Impact factor: 8.702

Review 2.  m6A Methylation in Cardiovascular Diseases: From Mechanisms to Therapeutic Potential.

Authors:  Longbo Li; Nannan Xu; Jia Liu; Zhenzhen Chen; Xu Liu; Junnan Wang
Journal:  Front Genet       Date:  2022-06-28       Impact factor: 4.772

Review 3.  N6-Methyladenosine RNA Methylation in Cardiovascular Diseases.

Authors:  Chi Liu; Lei Gu; Wenjuan Deng; Qianchao Meng; Nan Li; Guifeng Dai; Suli Yu; Hong Fang
Journal:  Front Cardiovasc Med       Date:  2022-04-29

4.  The m6A methyltransferase METTL3 regulates muscle maintenance and growth in mice.

Authors:  Jennifer M Petrosino; Scott A Hinger; Volha A Golubeva; Juan M Barajas; Lisa E Dorn; Chitra C Iyer; Hui-Lung Sun; W David Arnold; Chuan He; Federica Accornero
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 17.694

Review 5.  Role of N6-methyladenosine Modification in Cardiac Remodeling.

Authors:  ManTing Choy; Ruicong Xue; Yuzhong Wu; Wendong Fan; Yugang Dong; Chen Liu
Journal:  Front Cardiovasc Med       Date:  2022-02-10

6.  The lncRNA MIAT regulates CPT-1a mediated cardiac hypertrophy through m6A RNA methylation reading protein Ythdf2.

Authors:  Yiqing Yang; Muisha B Mbikyo; Junzhe Zhang; Yuan Zhang; Naijin Zhang; Zhao Li
Journal:  Cell Death Discov       Date:  2022-04-05

Review 7.  Emerging Roles and Mechanism of m6A Methylation in Cardiometabolic Diseases.

Authors:  Zujie Xu; Binbin Lv; Ying Qin; Bing Zhang
Journal:  Cells       Date:  2022-03-24       Impact factor: 6.600

Review 8.  Functional roles of epitranscriptomic marks in the cardiovascular system and disease: a narrative review.

Authors:  Mirolyuba Ilieva; Shizuka Uchida
Journal:  Ann Transl Med       Date:  2022-07

Review 9.  Emerging roles of the RNA modifications N6-methyladenosine and adenosine-to-inosine in cardiovascular diseases.

Authors:  Vilbert Sikorski; Antti Vento; Esko Kankuri
Journal:  Mol Ther Nucleic Acids       Date:  2022-07-20       Impact factor: 10.183

10.  YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy.

Authors:  Hongfei Xu; Zhen Wang; Miao Chen; Wenting Zhao; Tingting Tao; Liang Ma; Yiming Ni; Weidong Li
Journal:  Cell Biosci       Date:  2021-07-15       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.